PD-L1-targeted PET imaging for non-invasive assessment of immunotherapy response in lung cancer
Background
Immune checkpoint inhibitors have improved outcomes for several malignancies; however, there remains a lack of accurate, non-invasive methods to assess tumor PD-L1 expression levels and guide immunotherapy. This study aimed to evaluate the …